Switch theme
Sign up to access all valuation multiples
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
1999
136
LTM Revenue $3.0M
LTM EBITDA -$76.7M
$86.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Anteris Technologies US has a last 12-month revenue (LTM) of $3.0M and a last 12-month EBITDA of -$76.7M.
In the most recent fiscal year, Anteris Technologies US achieved revenue of $2.7M and an EBITDA of -$75.9M.
Anteris Technologies US expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Anteris Technologies US valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.0M | XXX | $2.7M | XXX | XXX | XXX |
| Gross Profit | $1.3M | XXX | $1.3M | XXX | XXX | XXX |
| Gross Margin | 45% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | -$76.7M | XXX | -$75.9M | XXX | XXX | XXX |
| EBITDA Margin | -2598% | XXX | -2809% | XXX | XXX | XXX |
| EBIT | -$80.9M | XXX | -$78.4M | XXX | XXX | XXX |
| EBIT Margin | -2742% | XXX | -2899% | XXX | XXX | XXX |
| Net Profit | -$79.8M | XXX | -$76.3M | XXX | XXX | XXX |
| Net Margin | -2702% | XXX | -2822% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Anteris Technologies US's stock price is $4.
Anteris Technologies US has current market cap of $134M, and EV of $86.8M.
See Anteris Technologies US trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $86.8M | $134M | XXX | XXX | XXX | XXX | $-2.98 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Anteris Technologies US has market cap of $134M and EV of $86.8M.
Anteris Technologies US's trades at 32.1x EV/Revenue multiple, and -1.1x EV/EBITDA.
Equity research analysts estimate Anteris Technologies US's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Anteris Technologies US has a P/E ratio of -1.7x.
See valuation multiples for Anteris Technologies US and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $134M | XXX | $134M | XXX | XXX | XXX |
| EV (current) | $86.8M | XXX | $86.8M | XXX | XXX | XXX |
| EV/Revenue | 29.4x | XXX | 32.1x | XXX | XXX | XXX |
| EV/EBITDA | -1.1x | XXX | -1.1x | XXX | XXX | XXX |
| EV/EBIT | -1.1x | XXX | -1.1x | XXX | XXX | XXX |
| EV/Gross Profit | 65.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.7x | XXX | -1.8x | XXX | XXX | XXX |
| EV/FCF | -1.1x | XXX | -1.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAnteris Technologies US's last 12 month revenue growth is 123%
Anteris Technologies US's revenue per employee in the last FY averaged $20K, while opex per employee averaged $0.6M for the same period.
Anteris Technologies US's rule of 40 is -1478% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Anteris Technologies US's rule of X is -2291% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Anteris Technologies US and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 123% | XXX | 92% | XXX | XXX | XXX |
| EBITDA Margin | -2598% | XXX | -2809% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -1478% | XXX | -2686% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -2291% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $20K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1043% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 1903% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 2946% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Anteris Technologies US acquired XXX companies to date.
Last acquisition by Anteris Technologies US was XXXXXXXX, XXXXX XXXXX XXXXXX . Anteris Technologies US acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Anteris Technologies US founded? | Anteris Technologies US was founded in 1999. |
| Where is Anteris Technologies US headquartered? | Anteris Technologies US is headquartered in United States of America. |
| How many employees does Anteris Technologies US have? | As of today, Anteris Technologies US has 136 employees. |
| Who is the CEO of Anteris Technologies US? | Anteris Technologies US's CEO is Mr. Wayne G. Paterson. |
| Is Anteris Technologies US publicy listed? | Yes, Anteris Technologies US is a public company listed on NAS. |
| What is the stock symbol of Anteris Technologies US? | Anteris Technologies US trades under AVR ticker. |
| When did Anteris Technologies US go public? | Anteris Technologies US went public in 2024. |
| Who are competitors of Anteris Technologies US? | Similar companies to Anteris Technologies US include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Anteris Technologies US? | Anteris Technologies US's current market cap is $134M |
| What is the current revenue of Anteris Technologies US? | Anteris Technologies US's last 12 months revenue is $3.0M. |
| What is the current revenue growth of Anteris Technologies US? | Anteris Technologies US revenue growth (NTM/LTM) is 123%. |
| What is the current EV/Revenue multiple of Anteris Technologies US? | Current revenue multiple of Anteris Technologies US is 29.4x. |
| Is Anteris Technologies US profitable? | Yes, Anteris Technologies US is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Anteris Technologies US? | Anteris Technologies US's last 12 months EBITDA is -$76.7M. |
| What is Anteris Technologies US's EBITDA margin? | Anteris Technologies US's last 12 months EBITDA margin is -2598%. |
| What is the current EV/EBITDA multiple of Anteris Technologies US? | Current EBITDA multiple of Anteris Technologies US is -1.1x. |
| What is the current FCF of Anteris Technologies US? | Anteris Technologies US's last 12 months FCF is -$75.9M. |
| What is Anteris Technologies US's FCF margin? | Anteris Technologies US's last 12 months FCF margin is -2572%. |
| What is the current EV/FCF multiple of Anteris Technologies US? | Current FCF multiple of Anteris Technologies US is -1.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
